You do realise that the price of the product that PLS sells has fallen by a lot more percentage-wise than PLS share price and that PLS is currently selling its product at a loss. But hey, let's not focus on that, because ignorance and denial is better than discussing the ACTUAL reasons for the share price decline
- Forums
- ASX - By Stock
- PLS
- Spodumene Prices
Spodumene Prices, page-4848
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PLS (ASX) to my watchlist
(20min delay)
|
|||||
Last
$3.09 |
Change
0.130(4.39%) |
Mkt cap ! $9.290B |
Open | High | Low | Value | Volume |
$3.05 | $3.14 | $3.01 | $56.76M | 18.39M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
27 | 45912 | $3.08 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.09 | 196197 | 30 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
23 | 49453 | 3.080 |
27 | 224122 | 3.070 |
21 | 338876 | 3.060 |
10 | 74107 | 3.050 |
9 | 87715 | 3.040 |
Price($) | Vol. | No. |
---|---|---|
3.090 | 194666 | 28 |
3.100 | 325415 | 20 |
3.110 | 95748 | 10 |
3.120 | 209895 | 22 |
3.130 | 158750 | 18 |
Last trade - 15.36pm 12/11/2024 (20 minute delay) ? |
Featured News
PLS (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online